Skip to main content

Quest to Use Orchid s Technology in Diagnostic Tests

NEW YORK, Dec. 14 – Orchid BioSciences said Friday it had granted Quest Diagnostics a non-exclusive license to use its SNP-IT technology in its diagnostic tests.

This deal marks the first time Orchid’s technology has been licensed for use in diagnostics.

Under the terms of the deal, Orchid of Princeton, NJ, received an upfront payment of an undisclosed amount and will also be entitled to royalties for diagnostic services Quest provides using Orchid’s technology.

Quest of Teterboro, NJ, has gained access to the SNP-IT technology through a deal with Applied Biosystems for its SNAPshot reagent kits. Orchid’s SNP-IT technology is embedded in the reagent kits, which Applied Biosystems markets. 

However, SNAPshot users aiming to provide commercial genotyping services must obtain an additional license from Orchid. 

"We are leveraging our initial propagation partnership with Applied Biosystems, which provides Orchid with an ongoing royalty stream on sales of SNAPshot kits, to establish a beachhead for our market leading SNP-IT technology in the critical clinical diagnostics services arena,” Russell Granzow, vice president of corporate development and strategy at Orchid, said in a statement.

Granzow noted that he expected to pen similar deals in the future.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.